Description:
Healthcare professionals and patients should use this application to search for potential drug-drug interactions between hepatitis drugs and other medications, as recommended by international treatment guidelines. Results are presented as a “Traffic Light” system (red, amber, yellow, green) to indicate the recommendation. A brief summary of each interaction is given. The application is available free of charge and has been developed by the Liverpool Drug Interactions Group at the University of Liverpool and Podmedics

Requirements:
This is an “offline” application that is downloaded to your device (~7.6 MB). An internet connection is not required to use the application, but is needed for downloading updates.

Why this application may be useful:
In hepatitis therapy, patients take more than one hepatitis medication at a time and possibly other drugs to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different hepatitis drugs and other medications that the HCV- and/or HBV-infected patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.hep-druginteractions.org.

This application is based on the original HEP iChart app but has been updated to provide universal support for both phones and tablets.

Maelezo:
wataalamu wa afya na wagonjwa wanapaswa kutumia hii ya maombi ya kutafuta uwezo mwingiliano wa madawa ya kulevya kati ya madawa hepatitis na dawa nyingine, kama ilivyopendekezwa na miongozo ya kimataifa ya matibabu. Matokeo ni iliyotolewa kama "Traffic Mwanga" mfumo (nyekundu, kahawia, njano, kijani) zinaonyesha mapendekezo. muhtasari wa kila mwingiliano ni kutolewa. maombi inapatikana bure bila malipo na imekuwa maendeleo na Liverpool Mwingiliano wa Madawa Group katika Chuo Kikuu cha Liverpool na Podmedics

mahitaji:
Hii ni "nje ya mkondo" maombi ambayo ni kupakuliwa kwa kifaa yako (~ 7.6 MB). uhusiano wa internet si required kutumia maombi, lakini inahitajika kwa ajili ya kushusha updates.

Kwa nini maombi hii inaweza kuwa na manufaa:
Katika hepatitis tiba, wagonjwa kuchukua zaidi ya moja hepatitis dawa wakati na madawa ya kulevya uwezekano mwingine kutibu hali ushirikiano uliopo. Wengi wa mchanganyiko wa madawa ya kulevya wana uwezo wa kiutendaji na hii inaweza kuathiri ama usalama wa mgonjwa au ufanisi wa matibabu. Kwa sababu hii mchanganyiko baadhi madawa ya kulevya haipaswi kutolewa wakati wote, wakati dawa nyingine inaweza kutumika pamoja na tahadhari, pengine kuhitaji marekebisho ya kipimo au wakati wa utawala. Maombi Hii ni mwongozo wa mwingiliano ambayo yanaweza kutokea kati ya madawa mbalimbali hepatitis na dawa nyingine ambazo HCV- na / au HBV-kuambukizwa na subira kitakachowekwa. maombi ni mara kwa mara updated kama data mpya kuibuka. maelezo kamili kuhusu mwingiliano yanaweza kupatikana katika www.hep-druginteractions.org.

Maombi Hii ni misingi ya awali programu HEP iChart lakini imekuwa updated kutoa msaada zima kwa ajili ya simu za wote na vidonge.